Close

IMAB Financial Facts

See Full Income Statement

See Full Balance Sheet

I-Mab Biopharma (IMAB) Earnings

  |   Expand Research on IMAB
Next EPS Date 5/29/24 EPS Growth Rate N/A
Average EPS % Beat Rate +2.1% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -0.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/29/24 Q124 N/A-$0.12 N/A N/AN/A N/A N/A N/A
3/27/24 Q423 N/A-$1.11 N/A N/AN/A N/A N/A N/A
11/29/23 Q323 N/A-$0.13 N/A N/AN/A N/A N/A N/A
8/17/23 Q223 N/A-$0.34 N/A N/A$1.67M N/A N/A N/A
5/31/23 Q123 N/A-$0.14 N/A N/AN/A N/A N/A N/A
3/31/23 Q422 N/A-$0.77 N/A N/A$17.5M N/A N/A N/A
11/30/22 Q322 N/A-$0.24 N/A N/AN/A N/A N/A N/A
8/30/22 Q222 -$0.99-$1.08 +$0.09$2.73M$30M N/A Details